US Drug Maker Merck to Help Produce Rival's COVID Vaccine
Agreement could ease Johnson & Johnson's slowed productionActualités similaires
Articles similaires à US Drug Maker Merck to Help Produce Rival's COVID Vaccine
Pfizer plans to produce up to 100 million doses of Omicron's new Covid vaccine by spring
The company said Monday that Pfizer will be able to manufacture 50 to 100 million...US Ramps Up Effort to Convince Young Adults COVID Vaccine is Safe
Outreach groups target young people for COVID-19 vaccination as demand for shots wanesActualités similaires
US Wants to Help India Produce Oxygen Fast
Washington has also promised to help India by providing it with vaccinesActualités similaires
Race to Produce COVID Vaccine May Cause Measles Jabs Shortage
Measles surged worldwide in 2019, reaching the highest number since 1996Actualités similaires
US Drug Maker Merck to Help Produce Rival's COVID Vaccine
Agreement could ease Johnson & Johnson's slowed productionActualités similaires
US Will Support Program to Share COVID Vaccine with Poor Countries, But Offers Few Details
Biden administration reiterates support for global initiative to ensure lower-income countries have access to the coronavirus vaccine but has not provided ...German Pharma Company Bayer to Produce New COVID Vaccine
CureVac vaccine still in testing phase; Bayer says it will not begin production until 2022US to Release Millions of COVID Vaccine Doses to Those 65 and Older
Doses were being held back to provide necessary second dose of vaccineActualités similaires
Moderna COVID-19 Vaccine Begins Rollout as US Races to Broaden Injection Campaign
Sites scheduled to start giving shots as soon as MondayActualités similaires
US Panel Expected to Endorse Second COVID-19 Vaccine
Outside expert advisers expected to recommend vaccine developed by ModernaActualités similaires
US Gives Favorable Review to Second COVID-19 Vaccine
Positive FDA review of Moderna vaccine comes as US hospitals ramp up inoculations with shot developed by Pfizer and BioNTechActualités similaires
US Allows Emergency COVID-19 Vaccine in Bid to End Pandemic
Initial doses are scarce and will be rationed as US joins Britain, other countries in scrambling to vaccinate as many people as possible ahead of winterActualités similaires
China Gave COVID-19 Vaccine Candidate to N. Korea's Kim, US Analyst Says
It was unclear which company had supplied its drug candidate to the Kims and whether it had proven to be safeActualités similaires
US Drug Maker Moderna Announces Experimental COVID-19 Vaccine is More than 90% Effective Against Virus
The news comes just a week after a joint effort by US-based Pfizer and German-based BioNTech announced a breakthroughActualités similaires
Experimental COVID-19 Therapeutic Drug No Help to Patients with Advanced Stage of Virus
Trial of potential therapeutic drug paused earlier this month due to safety concerns //Actualités similaires
Experimental COVID-19 Therapeutic Drug No Help to Hospitalized Patients, Says US Government Regulator/
Trial of potential therapeutic drug paused earlier this month due to safety concerns //Actualités similaires
US Drug Oversight Agency Issues New Guidelines on COVID-19 Vaccine Approval//
Rules formed by US Food and Drug Administration likely would push approval of potential vaccine past November 3 presidential electionActualités similaires
US Government Drug Agency Considering Stricter New Guidelines on Approval for COVID-19 Vaccine
If new guidelines adopted by US Food and Drug Administration, emergency authorization of new vaccine could come well after November 3 presidential election, ...US Drug Execs Promise COVID Vaccine Safety Before Seeking Government Approval
Unusual statement by nine competing firms comes as Trump pushes for vaccine approval before Election DayActualités similaires
US Declines to Take Part in Global Effort to Develop Global COVID-19 Vaccine ///
White House official cites involvement of corrupt World Health Organization for refusing to participate; Trump withdrew US from WHO in July, accusing the ...Actualités similaires
US Company to Begin Second Phase of Human Trials in South Africa for COVID-19 Vaccine
Second phase of human trials for COVID-19 vaccine underway in South Africa///Actualités similaires
US to Pay Johnson and Johnson $1 Billion for COVID-19 Vaccine
The drug maker is to deliver 100 million doses of a COVID-19 vaccineActualités similaires
US to Pay 2 Firms $1.95 Billion for COVID-19 Vaccine
Pfizer and BioNTech hope to deliver 100 million doses if they succeed in developing vaccineActualités similaires
Novavax Awarded $1.6 Billion to Develop US COVID-19 Vaccine
US government contract to develop treatments of coronavirus is the largest yetActualités similaires
Indonesia to Produce COVID Vaccine for Its Own Exclusive Use
Vaccine 'by Indonesia, from Indonesia, to Indonesia' being developed amid concerns about global distribution, country's national COVID-19 research team ...Actualités similaires
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
